When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FMS - ChemoCentryx withdraws conditional approval application for avacopan in Europe
Fresenius Medical Care AG
ChemoCentryx (CCXI+0.3%) has withdrawn its marketing application in Europe seeking conditional approval for avacopan (formerly CCX168) for the treatment of ANCA-associated vasculitis, an autoimmune disorder characterized by the inflammation and destruction of small vessels, a filing submitted a year ago based on Phase 2 data. Instead, it will wait for topline results from a larger Phase 3 trial called ADVOCATE, expected in Q4.
More news on: ChemoCentryx, Galenica AG ADR, Fresenius Medical Care AG & Co. KGAA, Healthcare stocks news,